The document also adds that the proposed changes by the WHO could give people the wrong idea, leading them to think that the current Schedule IV stance impedes research and that the international framework isn’t compatible with research. What they’re basically saying is that even if the United States acknowledges the benefits of reclassifying cannabis, the government is worried about how it would turn out.
Cannabis moves fast. New strains appear every season, each promising louder flavors, bigger yields, or…
What do you give someone who already has everything? That’s the question Distinctive Assets, the…
The road into the Mzintlava River Valley is not on any investment map. It bends…
On February 9th, 2026, the New York Times editorial board published a piece titled "It's…
A point-by-point look at SAM’s New York report finds a familiar pattern: selective data, overstated…
"The War on Drugs" is a 12-track musical history project chronicling America's century-long crusade against…